Clinical Dermatology Research JournalISSN: 2576-1439

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Alejandro Lobato-Berezo Author

allobe@hotmail.es

Subjects of specialization
Extravasation, Cytostatic agent, Chemotherapy, Trabectedin

Affiliation
Department of Dermatology, Hospital Universitario Severo Ochoa, Spain

Biography

Alejandro Lobato-Berezo is currently working in the Department of Dermatology in Hospital Universitario Severo Ochoa in Spain. he is having skills and expertise In Extravasation, Cytostatic agent,  Cytostatic agent, and    Trabectedin.

Publications

Case Report Subscription

Extravasation with Trabectedin(Yondelis: ET-743) Troubles with the Use of Cytostatic Agents

Author(s):

Alejandro Lobato-Berezo, Amparo Lucena-Campillo, Francisco Hidalgo and Antonio Aguilar-Martínez

Extravasation with Trabectedin (Yondelis: ET-743) Troubles with the Use of Cytostatic Agents

 

The use of chemotherapeutic agents can be the cause of local or systemic toxicity.  Extravasation is a serious phenomenon which can lead to chronic and irreversible side- effects. In 2007, trabectedin (Yondelis®; ET- 743) obtained a commercial license of the European Medicines Agency (EMA) for the treatment of adult patients with advanced soft tissue sarcoma after failure of anthracyclines and ifosfamide or who are unsuited to receive these agents. Since 2009, trabectedin in combination with pegylated liposomal doxor... view more»

Abstract HTML PDF

Google Scholars / Researchers Sites

Explore SciTechnol

GET THE APP